Abstract:Abstract Drug design targeting protein–protein interactions (PPIs) associated with the development of diseases has been one of the most important therapeutic strategies. Besides interrupting the PPIs with PPI inhibitors/blockers, increasing evidence shows that stabilizing the interaction between two interacting proteins may also benefit the therapy, such as the development of various types of molecular glues/stabilizers that mostly work by stabilizing the two interacting proteins to regulate the downstream biological effects. However, characterizing the stabilization effect of a stabilizer is usually hard or too complicated for traditional experiments since it involves ternary interactions [protein–protein–stabilizer (PPS) interaction]. Thus, developing reliable computational strategies will facilitate the discovery/design of molecular glues or PPI stabilizers. Here, by fully analyzing the energetic features of the binary interactions in the PPS ternary complex, we systematically investigated the performance of molecular mechanics Poisson-Boltzmann surface area (MM/PBSA) and molecular mechanics generalized Born surface area (MM/GBSA) methods on characterizing the stabilization effects of stabilizers in 14-3-3 systems. The results show that both MM/PBSA and MM/GBSA are powerful tools in distinguishing the stabilizers from the decoys (with area under the curves of 0.90–0.93 for all tested cases) and are reasonable for ranking protein–peptide interactions in the presence or absence of stabilizers as well (with the average Pearson correlation coefficient of ~0.6 at a relatively high dielectric constant for both methods). Moreover, to give a detailed picture of the stabilization effects, the stabilization mechanism is also analyzed from the structural and energetic points of view for individual systems containing strong or weak stabilizers. This study demonstrates a potential strategy to accelerate the discovery of PPI stabilizers.

Small-Molecule Stabilization of Protein-Protein Interactions: An Underestimated Concept in Drug Discovery?

What Makes a Good Protein–Protein Interaction Stabilizer: Analysis and Application of the Dual-Binding Mechanism

14‐3‐3 Protein‐Protein Interactions: From Mechanistic Understanding to their Small‐molecule Stabilization

Design Of Drug-Like Protein-Protein Interaction Stabilizers Guided By Chelation-Controlled Bioactive Conformation Stabilization

Targeting Protein-Protein Interaction by Small Molecules

Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

Methods to Profile the Macromolecular Targets of Small Compounds.

Characterizing the stabilization effects of stabilizers in protein–protein systems with end-point binding free energy calculations

Emerging Roles of Allosteric Modulators in the Regulation of Protein‐protein Interactions (ppis): A New Paradigm for PPI Drug Discovery

Structure-Based Optimization of Covalent, Small-Molecule Stabilizers of the 14-3-3σ/ERα Protein-Protein Interaction from Nonselective Fragments

Protein–protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays

Fragment-based Differential Targeting of PPI Stabilizer Interfaces

New insights into protein–protein interaction modulators in drug discovery and therapeutic advance

Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions

Fragment‐Based Stabilizers of Protein–Protein Interactions through Imine‐Based Tethering

Modulators of 14-3-3 Protein–Protein Interactions

Computational Approaches for the Design of Modulators Targeting Protein-Protein Interactions

Protein Allostery in Drug Discovery

Computational Methods-Guided Design of Modulators Targeting Protein-Protein Interactions (Ppis)

Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials

Rational design of small-molecule peptidomimetics for three pivotal protein secondary structures